Back to Clinical Trials Overview

Your search for "Endocrinology" returned 11 results:


A Phase III, multi-center, double-blind, randomized withdrawal study of LCI699 following a 24 week, single-arm, open-label dose titration and treatment period to evaluate the safety and efficacy of LCI699 for the treatment of patients with Cushing's disease
Principal Investigator(s): Eliza Geer

An Acromegaly open-label multi-center Safety monitoring program for treating patients with SOM230 (pasireotide) LAR who have need to receive medical therapy (ACCESS)
Principal Investigator(s): Eliza Geer

Hypothyroidism and The Risk of Peripheral Vascular Disease
Principal Investigator(s): Mazzeffi, Michael

An open label study to assess the safety and efficacy of COR-003 (2S 4R-Ketoconazole) in the treatment of Endogenous Cushing's syndrome
Principal Investigator(s): Eliza Geer

A randomized double-blind multicenter phase 3 study to evaluate the efficacy and safety of Pasireotide LAR in patients with Cushing's disease
Principal Investigator(s): Eliza Geer

Adipose Tissue Distribution/ Adipokines in Cushing's Disease
Principal Investigator(s): Geer, Eliza

Genetics & Neuroendocrinology of Short Stature
Principal Investigator(s): Rapaport, Robert

Glucocorticoid Receptor Blockade with Mifepristone in Patients with Mild Adrenal Hypercortisolism
Principal Investigator(s): Alice Levine

Molecular Analysis of Pituitary Tumors
Principal Investigator(s): Post, Kalmon

Body Composition & Metabolic Syndrome /Cushing's Disease
Principal Investigator(s): Geer, Eliza

Does Surgical Debulking Pituitary Adenomas Improve Responsiveness to Octreotide LAR in the treatment of acromegaly: An investigator-initated study
Principal Investigator(s): Post, Kalmon